Literature DB >> 15246019

Adverse events of desirable gain in immunocompetence: the Immune Restoration Inflammatory Syndromes.

Matthias Stoll1, Reinhold E Schmidt.   

Abstract

Augmentation of inflammation may occur during immune reconstitution in a immunocompromised host. This phenomenon is able to cause atypical inflammatory disorders, synonymously summarized as 'Immune Reconstitution Syndrome', 'Immune Restoration Disease' and 'Immune Restoration Inflammatory Syndrome' (IRIS). Immune reconstitution occurs, if temporarily use of immunosuppressive agents was terminated or if highly active antiretroviral therapy in human immunodeficiency virus positive individuals with secondary immunodeficiency was initiated. Unexpected deterioration of inflammatory disease and atypical clinical features, resembling symptoms of autoimmune disease may arise. They have to be distinguished from intercurrent infection and rheumatic disease, respectively. Treatment of IRIS would consist of both potential differential diagnoses: use of anti-inflammatory and immunosuppressive drugs like in autoimmune disorders as well as antimicrobial chemotherapy to decrease the burden of pathogen like in infectious disease. Therefore, awareness for IRIS is of increasing importance from a clinical point of view. However, diagnostic criteria and standards of treatment still have to be defined.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15246019     DOI: 10.1016/j.autrev.2003.09.005

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  9 in total

1.  [Immune reconstitution syndrome].

Authors:  D Meyer-Olson; D Ernst; M Stoll
Journal:  Z Rheumatol       Date:  2012-04       Impact factor: 1.372

2.  CD8 T cells modulate CD4 T-cell and eosinophil-mediated pulmonary pathology in pneumocystis pneumonia in B-cell-deficient mice.

Authors:  Steve D Swain; Nicole N Meissner; Allen G Harmsen
Journal:  Am J Pathol       Date:  2006-02       Impact factor: 4.307

3.  Pulmonary hypertension can be a sequela of prior Pneumocystis pneumonia.

Authors:  Steve D Swain; Soo Han; Ann Harmsen; Katie Shampeny; Allen G Harmsen
Journal:  Am J Pathol       Date:  2007-07-19       Impact factor: 4.307

4.  Immune reconstitution inflammatory syndrome in a unique clinical scenario.

Authors:  G Anubhav; N K Kamath
Journal:  Indian J Sex Transm Dis AIDS       Date:  2010-07

5.  Adjuvant corticosteroid therapy in hepatosplenic candidiasis-related iris.

Authors:  Cengiz Bayram; Ali Fettah; Nese Yarali; Abdurrahman Kara; Fatih Mehmet Azik; Betul Tavil; Bahattin Tunc
Journal:  Mediterr J Hematol Infect Dis       Date:  2012-03-13       Impact factor: 2.576

Review 6.  Lymphopenia, Lymphopenia-Induced Proliferation, and Autoimmunity.

Authors:  Ting-Ting Sheu; Bor-Luen Chiang
Journal:  Int J Mol Sci       Date:  2021-04-16       Impact factor: 5.923

7.  A Case of Steroid-Responsive Severe Pneumonia Following a Recent COVID-19 Infection in a Patient With Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infection.

Authors:  Seyedmohammad Pourshahid; Sara Khademolhosseini; Badri Giri; Moises Cossio; Edmundo Rubio
Journal:  Cureus       Date:  2022-07-12

8.  Paradoxical Immune Reconstitution Syndrome Presenting as Acute Respiratory Distress Syndrome in a Leukemia Patient during Neutrophil Recovery.

Authors:  Issam A Alawin; Bernard M Karnath
Journal:  Case Rep Hematol       Date:  2012-06-11

9.  A non-synonymous polymorphism in IL-23R Gene (rs1884444) is associated with reduced risk to schistosomiasis-associated Immune Reconstitution Inflammatory Syndrome in a Kenyan population.

Authors:  George O Ogola; Collins Ouma; Walter G Z O Jura; Erick O Muok; Robert Colebunders; Pauline N Mwinzi
Journal:  BMC Infect Dis       Date:  2014-06-10       Impact factor: 3.090

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.